Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples
- 1 April 2016
- journal article
- Published by Elsevier BV in Experimental and Molecular Pathology
- Vol. 100 (2), 287-293
- https://doi.org/10.1016/j.yexmp.2015.11.027
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81202960)
This publication has 21 references indexed in Scilit:
- Biomedical Applications of Trastuzumab: As a Therapeutic Agent and a Targeting LigandMedicinal Research Reviews, 2015
- A critical review of HER2-positive gastric cancer evaluation and treatment: From trastuzumab, and beyondCancer Letters, 2014
- Determination of HER2 Amplification Status on Tumour DNA by Digital PCRPLOS ONE, 2013
- Droplet Digital PCR Measurement of HER2 Copy Number Alteration in Formalin-Fixed Paraffin-Embedded Breast Carcinoma TissueClinical Chemistry, 2013
- Clinical significance of intratumoral HER2 heterogeneity in gastric cancerEuropean Journal of Cancer, 2013
- Droplet Digital™ PCR quantitation of HER2 expression in FFPE breast cancer samplesMethods, 2012
- High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy NumberAnalytical Chemistry, 2011
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- HER2 in gastric cancer: a new prognostic factor and a novel therapeutic targetAnnals of Oncology, 2008
- Assessment of a HER2 scoring system for gastric cancer: results from a validation studyHistopathology, 2008